These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31099622)

  • 1. Molecular Testing in Breast Cancer.
    Litton JK; Burstein HJ; Turner NC
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e1-e7. PubMed ID: 31099622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centers.
    Santa-Maria CA; Kruse M; Raska P; Weiss M; Swoboda A; Mutonga MB; Abraham J; Jain S; Nanda R; Montero AJ
    Breast Cancer Res Treat; 2017 Nov; 166(1):179-184. PubMed ID: 28752189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
    Pécuchet N; Legras A; Laurent-Puig P; Blons H
    Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical application and utility of genomic assays in early-stage breast cancer: key lessons learned to date.
    Chia SKL
    Curr Oncol; 2018 Jun; 25(Suppl 1):S125-S130. PubMed ID: 29910655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Signatures in Breast Cancer: Limitations of Available Predictive Data and the Importance of Prognosis.
    Esteva FJ
    Clin Adv Hematol Oncol; 2015 Jun; 13(6 Suppl 6):25-31. PubMed ID: 26191943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Testing in Breast Cancer: A Guide to Current Practices.
    Hagemann IS
    Arch Pathol Lab Med; 2016 Aug; 140(8):815-24. PubMed ID: 27472240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MAGIC survey in hormone receptor positive (HR+), HER2-negative (HER2-) breast cancer: When might multigene assays be of value?
    Aapro M; De Laurentiis M; Rea D; Bargallo Rocha JE; Elizalde R; Landherr L; Linderholm B; Mamounas E; Markopoulos C; Neven P; Petrovsky A; Rouzier R; Smit V; Svedman C; Schneider D; Thomssen C; Martin M
    Breast; 2017 Jun; 33():191-199. PubMed ID: 28441617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer.
    Lin PH; Kuo WH; Huang AC; Lu YS; Lin CH; Kuo SH; Wang MY; Liu CY; Cheng FT; Yeh MH; Li HY; Yang YH; Hsu YH; Fan SC; Li LY; Yu SL; Chang KJ; Chen PL; Ni YH; Huang CS
    Oncotarget; 2016 Feb; 7(7):8310-20. PubMed ID: 26824983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition.
    Afghahi A; Kurian AW
    Curr Treat Options Oncol; 2017 May; 18(5):27. PubMed ID: 28439798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do online prognostication tools represent a valid alternative to genomic profiling in the context of adjuvant treatment of early breast cancer? A systematic review of the literature.
    El Hage Chehade H; Wazir U; Mokbel K; Kasem A; Mokbel K
    Am J Surg; 2018 Jan; 215(1):171-178. PubMed ID: 28622841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream.
    Mack SC; Northcott PA
    J Clin Oncol; 2017 Jul; 35(21):2346-2354. PubMed ID: 28640705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Testing in Breast Cancer: Current Status and Future Directions.
    Sun L; Wu A; Bean GR; Hagemann IS; Lin CY
    J Mol Diagn; 2021 Nov; 23(11):1422-1432. PubMed ID: 34454106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multigene prognostic tests in breast cancer: past, present, future.
    Győrffy B; Hatzis C; Sanft T; Hofstatter E; Aktas B; Pusztai L
    Breast Cancer Res; 2015 Jan; 17(1):11. PubMed ID: 25848861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Genomic Landscape of Male Breast Cancers.
    Piscuoglio S; Ng CK; Murray MP; Guerini-Rocco E; Martelotto LG; Geyer FC; Bidard FC; Berman S; Fusco N; Sakr RA; Eberle CA; De Mattos-Arruda L; Macedo GS; Akram M; Baslan T; Hicks JB; King TA; Brogi E; Norton L; Weigelt B; Hudis CA; Reis-Filho JS
    Clin Cancer Res; 2016 Aug; 22(16):4045-56. PubMed ID: 26960396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.
    Graffeo R; Livraghi L; Pagani O; Goldhirsch A; Partridge AH; Garber JE
    Breast Cancer Res Treat; 2016 Dec; 160(3):393-410. PubMed ID: 27734215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
    Ross JS; Gay LM; Wang K; Ali SM; Chumsri S; Elvin JA; Bose R; Vergilio JA; Suh J; Yelensky R; Lipson D; Chmielecki J; Waintraub S; Leyland-Jones B; Miller VA; Stephens PJ
    Cancer; 2016 Sep; 122(17):2654-62. PubMed ID: 27284958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Biomarkers and Multigene Assays in Breast Cancer.
    Schwartzberg LS
    J Natl Compr Canc Netw; 2017 May; 15(5S):676-678. PubMed ID: 28515241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical application of high-throughput genomic technologies for treatment selection in breast cancer.
    Hansen AR; Bedard PL
    Breast Cancer Res; 2013; 15(5):R97. PubMed ID: 24135425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel.
    Moran O; Nikitina D; Royer R; Poll A; Metcalfe K; Narod SA; Akbari MR; Kotsopoulos J
    Breast Cancer Res Treat; 2017 Jan; 161(1):135-142. PubMed ID: 27798748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.